HHSN Blend - Hair, Skin & Nails Peptide

Hair, Skin and Nails research blend combining growth factors and copper peptides targeting three key tissues: hair follicle cycling (dermal papilla activation, Wnt/beta-catenin), skin collagen matrix (fibroblast stimulation), and nail keratin production (matrix cell proliferation).

The HHSN Blend combines multiple peptide and small-molecule components, each engaging distinct receptor systems and biochemical pathways relevant to follicular, dermal, and keratinocyte biology. Rather than acting through a single mechanism, the blend leverages convergent signaling cascades that together influence hair cycle dynamics, extracellular matrix remodeling, and epithelial regeneration.

Follicular Stem Cell Activation

Components such as GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) have been shown in preclinical studies to stimulate dermal papilla cell proliferation and prolong the anagen phase of the hair cycle. GHK-Cu modulates expression of BMP4, noggin, and FGF7, factors implicated in follicular morphogenesis. Copper-binding tripeptides also enhance vascular endothelial growth factor (VEGF) signaling around the hair bulb, supporting microcirculation that is necessary for follicle nourishment.

Wnt/β-Catenin Signaling

Several blend components converge on the Wnt/β-catenin pathway, a master regulator of hair follicle stem cell activation. Stabilization of β-catenin in dermal papilla cells promotes the telogen-to-anagen transition. Research peptides such as PTD-DBM and synthetic Wnt mimetics have been investigated for their ability to inhibit CXXC5–Dishevelled binding, thereby de-repressing Wnt signaling in follicular niches.

Collagen Synthesis and Dermal Remodeling

Matrikine peptides (e.g., Matrixyl/palmitoyl pentapeptide-4) act as fragments of collagen that signal fibroblasts to upregulate COL1A1, COL3A1, and hyaluronic acid synthase. This negative-feedback loop increases extracellular matrix density in the dermis. Copper peptides additionally inhibit matrix metalloproteinases (MMP-1, MMP-2), reducing collagen degradation while simultaneously stimulating new synthesis — a dual mechanism that has been validated in fibroblast culture models.

Keratin Production and Epithelial Differentiation

Biotinyl tripeptides and growth factor mimetics in the blend influence keratinocyte differentiation by modulating KRT14, KRT17, and involucrin expression. These pathways are essential for the formation of the hair shaft cortex and nail plate. Insulin-like growth factor (IGF-1) signaling is also engaged via PI3K/Akt cascades, supporting keratinocyte survival and proliferation.

Anti-Inflammatory and Antioxidant Effects

Chronic perifollicular inflammation is increasingly recognized as a driver of follicular miniaturization. Components with anti-inflammatory activity downregulate NF-κB and reduce pro-inflammatory cytokines (IL-6, TNF-α) in dermal models. Copper peptides additionally exhibit superoxide dismutase-like activity, neutralizing reactive oxygen species that contribute to oxidative damage of follicular DNA.

5α-Reductase Modulation

Certain peptide components have been investigated for indirect modulation of androgen metabolism in the scalp microenvironment, though this remains an active area of preclinical investigation. The combined mechanisms create a multi-pathway approach that distinguishes the HHSN blend from monotherapy research compounds.

The HHSN Blend is a research-grade multi-component formulation combining peptides and cofactors selected for their documented activity in dermal, follicular, and keratinocyte research models. Because it is a proprietary blend, no single molecular formula, CAS number, or sequence describes the product as a whole. Instead, each constituent is characterized individually below.

Physical Characteristics

Each component is individually synthesized and characterized prior to blending. Exact ratios are proprietary, but the formulation is optimized to deliver complementary signaling across the Wnt/β-catenin, TGF-β, and matrikine pathways most relevant to follicular and dermal research applications. Researchers requiring single-component preparations for mechanistic isolation should refer to AminoCore Research's individual product listings for GHK-Cu, Matrixyl, and Thymosin β4.

The HHSN Blend is supplied as a lyophilized powder containing multiple peptide species. Because copper-containing peptides and matrikines have distinct solubility profiles, careful reconstitution technique is essential to preserve activity and ensure homogeneous distribution of all components.

Recommended Reconstitution Protocol

1. Equilibrate the vial: Remove the lyophilized blend from -20°C storage and allow it to reach room temperature (approximately 20-30 minutes) before opening. This prevents condensation that can compromise the powder.
2. Select diluent: Bacteriostatic water (0.9% benzyl alcohol) is the standard diluent for research reconstitution. Sterile water for injection may also be used for short-term studies.
3. Calculate concentration: A typical reconstitution ratio is 2 mL of bacteriostatic water per 10 mg of blend, yielding a 5 mg/mL working concentration. Adjust based on experimental requirements.
4. Inject slowly: Direct the diluent stream down the inner wall of the vial rather than onto the powder cake. This minimizes mechanical shear on peptide bonds.
5. Dissolve gently: Swirl the vial in a slow circular motion for 30-60 seconds. Do not shake or vortex — agitation can denature peptides and cause copper-complex dissociation.
6. Allow full dissolution: If particulate remains, let the vial rest at room temperature for 5-10 minutes, then swirl again. Complete dissolution may take up to 15 minutes for multi-component blends.
7. Inspect visually: The reconstituted solution should appear clear to faintly blue-tinted (due to copper peptide content). Discard if turbidity, precipitation, or unusual color is observed.

Component-Specific Handling Notes

• Copper peptides (GHK-Cu): Avoid contact with reducing agents (ascorbic acid, glutathione) which can dissociate the Cu²⁺ ion from the tripeptide complex.
• Matrikines: Palmitoylated peptides have surfactant-like properties and may foam if agitated — another reason to avoid vortexing.
• pH sensitivity: The blend is most stable at pH 5.5-7.0. Avoid strongly alkaline buffers which can hydrolyze peptide bonds.
• Light exposure: Protect reconstituted solutions from prolonged UV exposure, as some components are photosensitive.
• Cross-contamination: Use sterile technique throughout; multi-component blends are more susceptible to microbial degradation than single peptides.

All handling should be performed in a laboratory setting by trained personnel using appropriate PPE. The product is intended exclusively for in vitro and preclinical research applications.

Proper storage is critical for maintaining the integrity of multi-peptide blends such as HHSN, which contain components with differing stability profiles including copper-bound tripeptides, growth factor mimetics, and signal peptides. Each component class has its own susceptibilities to temperature, light, oxidation, and hydrolysis, and the storage protocol below reflects the most conservative recommendations across all included peptides.

Lyophilized (Powder) Storage

• Long-term storage: Store sealed lyophilized vials at -20°C in a frost-free freezer. Under these conditions, the blend is expected to remain stable for 24+ months based on published peptide stability data for analogous compounds.
• Short-term storage: Vials may be kept at 2-8°C (standard laboratory refrigeration) for up to 60 days prior to reconstitution.
• Transit conditions: Brief exposure to ambient temperature (15-25°C) during shipping for up to 7-10 days does not significantly impact lyophilized peptide integrity.
• Protect from light: Store vials in original packaging or amber containers. GHK-Cu and copper-coordinated peptides may undergo photochemical changes if exposed to direct UV light for prolonged periods.

Reconstituted Solution Storage

• Refrigerated (2-8°C): Once reconstituted in bacteriostatic water or sterile saline, the solution should be stored at 2-8°C and used within 14-28 days. Aqueous solutions of copper peptides are more susceptible to oxidation than the lyophilized form.
• Avoid freeze-thaw cycles: Repeated freezing and thawing of reconstituted solutions can cause peptide aggregation, loss of activity, and copper dissociation in GHK-Cu. If long-term storage of reconstituted material is necessary, aliquot into single-use volumes and freeze at -20°C or -80°C.

Component-Specific Stability Notes

• GHK-Cu: The copper-peptide complex is most stable at slightly acidic to neutral pH (5.5-7.0). Strongly alkaline conditions or chelating agents (EDTA) may disrupt the Cu²⁺ coordination.
• Methionine-containing peptides: Protect from oxidative stress; avoid prolonged exposure to dissolved oxygen. Consider purging reconstituted aliquots with nitrogen or argon for extended storage.
• Disulfide-containing components: Maintain reducing-neutral conditions to preserve intramolecular disulfide bonds. Avoid contact with thiol reagents (DTT, β-mercaptoethanol) unless intentionally used in assay protocols.

Quality Verification

For long-stored material, investigators may verify peptide integrity prior to use via HPLC analysis or absorbance measurement at 280 nm. Visible discoloration of GHK-Cu solutions (deepening blue-purple beyond initial color) may indicate copper redox changes and warrants fresh reconstitution.